Verve Therapeutics: How To Build A Gene Editing Biotech
Source: Life Science Leader
By Ben Comer, Chief Editor, Life Science Leader
In 2016, Sekar Kathiresan entered a grant competition created by the American Heart Association (AHA). The competition, called One Brave Idea, awarded $75 million to a single person judged to have the best, or bravest, idea for curing heart disease, with funding provided by the AHA, Alphabet’s Verily, and AstraZeneca. Kathiresan, at the time a professor at Harvard Medical School and leader of a Broad Institute human genetics research lab, entered his idea for a onetime therapy to permanently lower LDL cholesterol levels (i.e., “bad” cholesterol).
He didn’t win.
access the Magazine Article!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Life Science Leader? Subscribe today.
Subscribe to Life Science Leader
X
Subscribe to Life Science Leader
This website uses cookies to ensure you get the best experience on our website. Learn more